期刊
BRIEFINGS IN BIOINFORMATICS
卷 19, 期 6, 页码 1172-1182出版社
OXFORD UNIV PRESS
DOI: 10.1093/bib/bbx047
关键词
MOA of drug synergy; combinational drugs; in silico technology; network pharmacology
资金
- National High Technology Research and Development Program ('863' Program) of China [2012AA020405]
- National Natural Science Foundation of China [31671379]
Accumulated empirical clinical experience, supported by animal or cell line models, has initiated efforts of predicting synergistic combinatorial drugs with more-than-additive effect compared with the sum of the individual agents. Aiming to construct better computational models, this review started from the latest updated data resources of combinatorial drugs, then summarized the reported mechanism of the known synergistic combinations from aspects of drug molecular and pharmacological patterns, target network properties and compound functional annotation. Based on above, we focused on the main in silico strategies recently published, covering methods of molecular modeling, mathematical simulation, optimization of combinatorial targets and pattern-based statistical/learning model. Future thoughts are also discussed related to the role of natural compounds, drug combination with immunotherapy and management of adverse effects. Overall, with particular emphasis on mechanism of action of drug synergy, this review may serve as a rapid reference to design improved models for combinational drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据